AGLE Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (27 Nov 2023 @ 22:00):

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases...

Stats
Tagesvolumen	43 238.00
Durchschnittsvolumen	59 537.00
Marktkapitalisierung	48.63M
EPS	$0 ( 2024-03-07 )
Nächstes Ertragsdatum	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.162
ATR14	$2.39 (12.36%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-29	Fairmount Funds Management Llc	Buy	406 038	Common Stock
2023-12-29	Fairmount Funds Management Llc	Sell	3 435 480	Common Stock
2023-12-22	Burrows Scott L	Buy	134 953	Common Stock
2023-12-07	Fairmount Funds Management Llc	Buy	16 667	Series B Preferred Stock
2023-11-22	Albers Jeffrey W.	Buy	50 000	Stock Option (Right to Buy)

INSIDER POWER
-5.28
Last 85 transactions
Buy: 64 136 392 \| Sell: 71 129 759

Volumen Korrelation

Lang: 0.44 (neutral)

Kurz: -0.73 (moderate negative)

Signal:(64.735) Neutral

Aeglea Bio Therapeutics Korrelation

10 Am meisten positiv korreliert
GAINL	0.987
RETA	0.975
PRVB	0.967
ULBI	0.966
RDUS	0.964
SQL	0.96
HURN	0.948
CSSE	0.946
SONN	0.945
SGMO	0.945

10 Am meisten negativ korreliert
BOCH	-0.967
LMRK	-0.964
SBNYP	-0.962
SHSP	-0.956
TIOA	-0.944
MSDA	-0.941
ANIK	-0.939
MSDAU	-0.938
SKYA	-0.938
QADA	-0.937

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Aeglea Bio Therapeutics Korrelation - Währung/Rohstoff

0.45
( neutral )

0.68
( moderate )

-0.01
( neutral )

0.66
( moderate )

-0.79
( moderate negative )

-0.36
( neutral )

Aeglea Bio Therapeutics Finanzdaten

Annual	2022
Umsatz:	$2.33M
Bruttogewinn:	$2.33M (100.00 %)
EPS:	$-24.86

FY	2022
Umsatz:	$2.33M
Bruttogewinn:	$2.33M (100.00 %)
EPS:	$-24.86

FY	2021
Umsatz:	$18.74M
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.233

FY	2020
Umsatz:	$0.00
Bruttogewinn:	$0.00 (0.00 %)
EPS:	$-1.520

Financial Reports:

No articles found.

Aeglea Bio Therapeutics

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.